| Title | Neuropsychopharmacology |
| Abbreviation | Neuropsychopharmacology |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Pharmacology (Q1); Psychiatry and Mental Health (Q1) |
| h-index | 258 |
| Overall Rank/Ranking | 744 |
| SCImago Journal Rank (SJR) | 2.944 |
| Impact Score | 6.64 |
| Publisher | Springer Nature |
| Country | Switzerland |
| ISSN | 0893133X, 1740634X |
| Best Quartile | Q1 |
| Coverage History | 1987-2025 |
Neuropsychopharmacology is a journal covering the technologies/fields/categories related to Pharmacology (Q1); Psychiatry and Mental Health (Q1). It is published by Springer Nature. The overall rank of Neuropsychopharmacology is 744. According to SCImago Journal Rank (SJR), this journal is ranked 2.944. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 258. The best quartile for this journal is Q1.
The ISSN of Neuropsychopharmacology journal is 0893133X, 1740634X. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Neuropsychopharmacology is cited by a total of 5212 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Neuropsychopharmacology is 6.64, which is computed in 2025 as per its definition. Neuropsychopharmacology IF is increased by a factor of 0.8 and approximate percentage change is 13.7% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Neuropsychopharmacology is 6.64. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 6.64 |
| 2023 | 5.84 |
| 2022 | 6.30 |
| 2021 | 6.59 |
| 2020 | 5.65 |
| 2019 | 5.69 |
| 2018 | 6.43 |
| 2017 | 6.07 |
| 2016 | 6.06 |
| 2015 | 6.21 |
| 2014 | 6.83 |
Neuropsychopharmacology has an h-index of 258. It means 258 articles of this journal have more than 258 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Neuropsychopharmacology is 0893133X, 1740634X. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Neuropsychopharmacology is 744. According to SCImago Journal Rank (SJR), this journal is ranked 2.944. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.944 |
| 2023 | 2.743 |
| 2022 | 2.385 |
| 2021 | 2.277 |
| 2020 | 2.704 |
| 2019 | 3.122 |
| 2018 | 3.205 |
| 2017 | 3.327 |
| 2016 | 3.747 |
| 2015 | 3.573 |
| 2014 | 3.821 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 744 |
| 2023 | 794 |
| 2022 | 975 |
| 2021 | 1001 |
| 2020 | 770 |
| 2019 | 620 |
| 2018 | 582 |
| 2017 | 541 |
| 2016 | 452 |
| 2015 | 466 |
| 2014 | 427 |
Neuropsychopharmacology is published by Springer Nature. It's publishing house is located in Switzerland. Coverage history of this journal is as following: 1987-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Neuropsychopharmacology is Neuropsychopharmacology. This abbreviation ('Neuropsychopharmacology') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmacology (Q1); Psychiatry and Mental Health (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Neuropsychopharmacology latest impact IF is 6.64. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 6.83 (2014) and 5.65 (2020), respectively, in the last 11 years. Moreover, its average IS is 6.21 in the previous 11 years.
The Neuropsychopharmacology has an SJR (SCImago Journal Rank) of 2.944, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 3.821 in 2014 and the lowest being 2.277 in 2021. Furthermore, the average SJR of the Neuropsychopharmacology over the previous 11-year period stands at 6.21.
The latest h-index of the Neuropsychopharmacology is 258.
The Neuropsychopharmacology is published by the Springer Nature, with its country of publication being the Switzerland.
The Neuropsychopharmacology is currently ranked 744 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 427 in 2014 and its lowest position of 1001 in 2021.
The standard ISO4 abbreviation for the Neuropsychopharmacology is Neuropsychopharmacology.
Neuropsychopharmacology is classified as a journal that the Springer Nature publishes.
The Neuropsychopharmacology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Neuropsychopharmacology is assigned the following International Standard Serial Numbers (ISSN): 0893133X, 1740634X.
The best quartile for the Neuropsychopharmacology is Q1 (2024).
The Neuropsychopharmacology coverage history can be summarized as follows: 1987-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Business: Theory and Practice | journal | 16073 | Vilnius Gediminas Technical University | 31 | 2.45 |
| Applied Ecology and Environmental Research | journal | 19122 | Corvinus University of Budapest | 48 | 0.84 |
| SPE Production and Operations Symposium, Proceedings | conference and proceedings | 15907 | 21 | 0.00 | |
| CESifo Economic Studies | journal | 17776 | Oxford University Press | 36 | 0.89 |
| Archives of Phytopathology and Plant Protection | journal | 16692 | Taylor and Francis Ltd. | 35 | 1.42 |
| Air and Space Power Journal (discontinued) | journal | 28397 | AU Press | 9 | 0.20 |
| Journal of Education and Work | journal | 8987 | Brill Academic Publishers | 47 | 2.08 |
| Libyan Studies | journal | 21508 | Cambridge University Press | 10 | 0.14 |
| European Surgery - Acta Chirurgica Austriaca | journal | 18136 | Springer Medizin | 25 | 0.68 |
| Biological Procedures Online | journal | 5232 | BioMed Central Ltd | 51 | 4.00 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 6.64 |
| 2023 | 5.84 |
| 2022 | 6.30 |
| 2021 | 6.59 |
| 2020 | 5.65 |
| 2019 | 5.69 |
| 2018 | 6.43 |
| 2017 | 6.07 |
| 2016 | 6.06 |
| 2015 | 6.21 |
| 2014 | 6.83 |
